Akers Biosciences Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Akers Biosciences Inc
CIK #0001321834
EDGAR Form CIK 2011 - 2026
10-K [0001321834]
10-Q [0001321834]
3 [0001321834]
4 [0001321834]
5 [0001321834]
8-K [0001321834]
D [0001321834]
SC 13D [0001321834]
SC 13G [0001321834]
Form 13D/13G Filer Form 13D/13G Subject Filed
Pharmacyte Biotech Inc MYMD Pharmaceuticals Inc [2024-05-30]
Global X Management Co LLC MYMD Pharmaceuticals Inc [2024-02-14]
Duffey Samuel S MYMD Pharmaceuticals Inc [2022-09-08]
Williams Caroline C MYMD Pharmaceuticals Inc [2021-04-27]
Mainfield Enterprises Inc Akers Biosciences Inc [2021-02-18]
Intracoastal Capital LLC Akers Biosciences Inc [2020-11-20]
Intracoastal Capital LLC Akers Biosciences Inc [2020-05-26]
Intracoastal Capital LLC Akers Biosciences Inc [2020-04-17]
Hudson Bay Capital Management LP Akers Biosciences Inc [2020-01-09]
Intracoastal Capital LLC Akers Biosciences Inc [2019-12-19]
View All
Form 3/4/5 Subject 2011 - 2026
Voss Chelsea Sierra
Q/C Technologies Inc
Bernstein Bruce
Friscia Stephen
Glass Mitchell
Silverman Joshua
White Billy Joe
Nuvilex Inc
Rauch Gary M
Rhodes Ian Thomas
Rivard Paul
Kaplin Adam
Uzonwanne Jude
Eagle Craig
Schreiber Christopher C
Chapman Christopher C JR
Williams Caroline C
Schroeder Robert C
Benson Stuart M
Gerber Sander
Hudson Bay Capital Management LP
Yeaton Howard
Tarbox Richard C III
Gormally John J
Knox Brandon Thomas
Akers Raymond Francis Jr
Knox Thomas J
Andrews Robert E
Bokhari Raza
Moran Gavin
Nicolette Thomas Albert
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Q/C Technologies Inc QCLS
Employee Stock Option (Right to Buy) · derivative
2026-01-16 Grant 212,500 $0.00
Q/C Technologies Inc QCLS
Common stock
2026-01-16 Grant 25,000 $0.00
Q/C Technologies Inc QCLS
Common stock
2026-01-16 Grant 212,500 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-11-14 Grant 11,420 $0.00
Q/C Technologies Inc QCLS
Warrants · derivative
2025-11-14 Buy 889,865
Q/C Technologies Inc QCLS
Common stock
2025-11-14 Grant 11,420 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-11-14 Grant 22,839 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-11-14 Grant 25,000 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-11-14 Grant 22,839 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-11-14 Grant 91,356 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-10-03 Grant 1,080 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-10-03 Grant 2,161 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-10-03 Grant 8,644 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-10-03 Grant 1,080 $0.00
Q/C Technologies Inc QCLS
Common stock
2025-10-03 Grant 2,161 $0.00
Q/C Technologies Inc QCLS
Series H Convertible Preferred Stock · derivative
2025-09-04 Buy 889,865
Q/C Technologies Inc TNFA
Employee Stock Option (Right to Buy) · derivative
2025-04-17 Grant 125,000 $0.00
Q/C Technologies Inc TNFA
Employee Stock Option (Right to Buy) · derivative
2025-04-17 Grant 25,000 $0.00
Q/C Technologies Inc TNFA
Employee Stock Option (Right to Buy) · derivative
2025-04-17 Grant 75,000 $0.00
Q/C Technologies Inc MYMD
Common stock
2023-08-24 Buy 150,000 $1.11 166,500
showing 20 of 128 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com